While Cynthia Calvillo may have recently failed a USADA drug test earlier this year, it won’t keep her out of competition for long.
No. 9 ranked Strawweight, Cynthia Calvillo has accepted a six-month suspension from the United States Anti-Doping Agency (USADA) after an in-competition drug test came back positive for Carboxy-Tetrahydrocannabinol, a marijuana metabolite otherwise known as THC, last December.
The test result was collected on Dec. 30, 2017, the same day as Calvillo’s most recent fight at UFC 219 in Las Vegas. At that event, Calvillo dropped a unanimous decision to former UFC Strawweight champion Carla Esparza, the first loss of her pro career.
Calvillo’s (6-1, 3-1 in UFC) suspension can be reduced to three months pending completion of a USADA-approved drug awareness and management program. Should Calvillo receive a reduced suspension, she will be eligible to compete again by March 30 at the end this month, or by June 30 under the maximum penalty currently enforced.
Because the associated bout occurred in Las Vegas, Calvillo could receive further sanctions from the Nevada State Athletic Commission if they so choose.
While the commissions and USADA are far more lenient these days on fighters who test for marijuana or similar substances, the punishment comes due to Calvillo’s positive test occurring around the 48 hour period before and after he scheduled bout.